Literature DB >> 24625239

Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male Asian Indians with nonalcoholic fatty liver disease.

Priyanka Nigam1, Suryaprakash Bhatt, Anoop Misra, Davinder S Chadha, Meera Vaidya, Jharna Dasgupta, Qadar M A Pasha.   

Abstract

OBJECTIVE: We investigated the effects of dietary intervention with canola or olive oil in comparison with commonly used refined oil in Asian Indians with nonalcoholic fatty liver disease (NAFLD). SUBJECTS AND METHODS: This was a 6-month intervention study including 93 males with NAFLD, matched for age and body mass index (BMI). Subjects were randomized into three groups to receive olive oil (n=30), canola oil (n=33), and commonly used soyabean/safflower oil (control; n=30) as cooking medium (not exceeding 20 g/day) along with counseling for therapeutic lifestyle changes. The BMI, fasting blood glucose (FBG) and insulin levels, lipids, homeostasis model of assessment for insulin resistance (HOMA-IR), HOMA denoting β-cell function (HOMA-βCF), and disposition index (DI) were measured at pre- and post-intervention. Data were analyzed with one-way analysis of variance (ANOVA) and Tukey's Honestly Significant Difference multiple comparison test procedures.
RESULTS: Olive oil intervention led to a significant decrease in weight and BMI (ANOVA, P=0.01) compared with the control oil group. In a comparison of olive and canola oil, a significant decrease in fasting insulin level, HOMA-IR, HOMA-βCF, and DI (P<0.001) was observed in the olive oil group. Pre- and post-intervention analysis revealed a significant increase in high-density lipoprotein level (P=0.004) in the olive oil group and a significant decrease in FBG (P=0.03) and triglyceride (P=0.02) levels in the canola oil group. The pre- and post-intervention difference in liver span was significant only in the olive (1.14 ± 2 cm; P<0.05) and canola (0.66 ± 0.33 cm; P<0.05) oil groups. In the olive and canola oil groups, post-intervention grading of fatty liver was reduced significantly (grade I, from 73.3% to 23.3% and from 60.5% to 20%, respectively [P<0.01]; grade II, from 20% to 10% and from 33.4% to 3.3%, respectively [P<0.01]; and grade III, from 6.7% to none and from 6.1% to none, respectively). In contrast, in the control oil group no significant change was observed.
CONCLUSIONS: Results suggest significant improvements in grading of fatty liver, liver span, measures of insulin resistance, and lipids with use of canola and olive oil compared with control oils in Asian Indians with NAFLD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24625239     DOI: 10.1089/dia.2013.0178

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  27 in total

1.  The Effect of Canola Oil on Body Weight and Composition: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.

Authors:  Hamidreza Raeisi-Dehkordi; Mojgan Amiri; Karin H Humphries; Amin Salehi-Abargouei
Journal:  Adv Nutr       Date:  2019-05-01       Impact factor: 8.701

Review 2.  Abdominal obesity and type 2 diabetes in Asian Indians: dietary strategies including edible oils, cooking practices and sugar intake.

Authors:  S Gulati; A Misra
Journal:  Eur J Clin Nutr       Date:  2017-06-14       Impact factor: 4.016

3.  Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation.

Authors:  Pablo Pérez-Martínez; Dimitri P Mikhailidis; Vasilios G Athyros; Mónica Bullo; Patrick Couture; María I Covas; Lawrence de Koning; Javier Delgado-Lista; Andrés Díaz-López; Christian A Drevon; Ramón Estruch; Katherine Esposito; Montserrat Fitó; Marta Garaulet; Dario Giugliano; Antonio García-Ríos; Niki Katsiki; Genovefa Kolovou; Benoît Lamarche; Maria Ida Maiorino; Guillermo Mena-Sánchez; Araceli Muñoz-Garach; Dragana Nikolic; José M Ordovás; Francisco Pérez-Jiménez; Manfredi Rizzo; Jordi Salas-Salvadó; Helmut Schröder; Francisco J Tinahones; Rafael de la Torre; Ben van Ommen; Suzan Wopereis; Emilio Ros; José López-Miranda
Journal:  Nutr Rev       Date:  2017-05-01       Impact factor: 7.110

4.  Type 2 diabetes in Asia: where do we go from here?

Authors:  M Soares; M J Müller
Journal:  Eur J Clin Nutr       Date:  2017-07       Impact factor: 4.016

5.  Oleic acid protects insulin-secreting INS-1E cells against palmitic acid-induced lipotoxicity along with an amelioration of ER stress.

Authors:  Xiaohong Liu; Xin Zeng; Xuanming Chen; Ruixi Luo; Linzhao Li; Chengshi Wang; Jingping Liu; Jingqiu Cheng; Yanrong Lu; Younan Chen
Journal:  Endocrine       Date:  2019-02-18       Impact factor: 3.633

Review 6.  Obesity in South Asia: Phenotype, Morbidities, and Mitigation.

Authors:  Anoop Misra; Ranil Jayawardena; Shajith Anoop
Journal:  Curr Obes Rep       Date:  2019-03

Review 7.  Dietary approach in the treatment of nonalcoholic fatty liver disease.

Authors:  Silvia Marinho Ferolla; Luciana Costa Silva; Maria de Lourdes Abreu Ferrari; Aloísio Sales da Cunha; Flaviano Dos Santos Martins; Cláudia Alves Couto; Teresa Cristina Abreu Ferrari
Journal:  World J Hepatol       Date:  2015-10-28

Review 8.  Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease.

Authors:  Vikas Gupta; Xian-Jun Mah; Maria Carmela Garcia; Christina Antonypillai; David van der Poorten
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

9.  The effects of canola and olive oils on insulin resistance, inflammation and oxidative stress in women with type 2 diabetes: a randomized and controlled trial.

Authors:  Masoumeh Atefi; Gholam Reza Pishdad; Shiva Faghih
Journal:  J Diabetes Metab Disord       Date:  2018-05-23

10.  Cooking Oil Consumption Is Positively Associated with Risk of Type 2 Diabetes in a Chinese Nationwide Cohort Study.

Authors:  Pan Zhuang; Lei Mao; Fei Wu; Jun Wang; Jingjing Jiao; Yu Zhang
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.